Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Pedro Afonso, Maria Luísa Figueira & Teresa Paiva. (2014) Sleep–wake patterns in schizophrenia patients compared to healthy controls. The World Journal of Biological Psychiatry 15:7, pages 517-524.
Read now
Read now
Articles from other publishers (27)
Stephen HardmanElizabeth O'Mahony. (2022) Is there a role for melatonin in the treatment of schizophrenia?. Progress in Neurology and Psychiatry 26:3, pages 16-19.
Crossref
Crossref
Alexandre González-Rodríguez, José Haba-Rubio, Judith Usall, Mentxu Natividad, Virginia Soria, Javier Labad & José A. Monreal. (2022) Hormone Targets for the Treatment of Sleep Disorders in Postmenopausal Women with Schizophrenia: A Narrative Review. Clocks & Sleep 4:1, pages 52-65.
Crossref
Crossref
Lindsay M. Melhuish Beaupre, Gregory M. Brown, Vanessa F. Gonçalves & James L. Kennedy. (2021) Melatonin’s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders. Translational Psychiatry 11:1.
Crossref
Crossref
Filiz Ozsoy, Serbulent Yigit, Ayse Feyda Nursal, Muberra Kulu & Nevin Karakus. (2021) The Impact of PER3 VNTR Polymorphism on the Development of Schizophrenia in a Turkish Population. Cytology and Genetics 55:2, pages 188-193.
Crossref
Crossref
William H. WalkerIIII, James C. Walton & Randy J. Nelson. 2021. The Human Hypothalamus: Anterior Region. The Human Hypothalamus: Anterior Region
259
270
.
Archana Mishra, Rituparna Maiti, Biswa Ranjan Mishra, Monalisa Jena, Santanu Nath & Pallabi Sahu. (2020) Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia: A randomized controlled trial. European Neuropsychopharmacology 31, pages 109-118.
Crossref
Crossref
William H. WalkerIIII, James C. Walton, A. Courtney DeVries & Randy J. Nelson. (2020) Circadian rhythm disruption and mental health. Translational Psychiatry 10:1.
Crossref
Crossref
Kate Ryan Kuhlman, Nestor L. Lopez-Duran & Zahra Mousavi. 2020. Salivary Bioscience. Salivary Bioscience
471
501
.
Yeni KimKrishna C. VadodariaZsolt LenkeiTadafumi KatoFred H. GageMaria C. MarchettoRenata Santos. (2019) Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders. Antioxidants & Redox Signaling 31:4, pages 275-317.
Crossref
Crossref
Camilla Kienast, Hanns-Christian Gunga & Mathias Steinach. (2019) Neuropeptide Y – Its role in human performance and extreme environments. REACH 14-15, pages 100032.
Crossref
Crossref
Marco Aurélio Vinhosa Bastos Jr.Paulo Roberto Haidamus de Oliveira Bastos, Renata Boschi Portella, Leonardo Fabrício Gomes Soares, Ricardo Brilhante Conde, Paulo Milton Fernandes RodriguesJr.Jr. & Giancarlo Lucchetti. (2019) Pineal gland and schizophrenia: A systematic review and meta-analysis. Psychoneuroendocrinology 104, pages 100-114.
Crossref
Crossref
Cigdem Sahbaz, Omer Faruk Özer, Ayse Kurtulmus, Ismet Kırpınar, Fikrettin Sahin & Sinan Guloksuz. (2019) Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia. Metabolic Brain Disease 34:3, pages 865-874.
Crossref
Crossref
Zi Ying Wee, Samantha Wei Lee Yong, Qian Hui Chew, Cuntai Guan, Tih Shih Lee & Kang Sim. (2019) Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review. Journal of Neural Transmission 126:5, pages 531-558.
Crossref
Crossref
Tsutomu Takahashi, Mihoko Nakamura, Daiki Sasabayashi, Yumiko Nishikawa, Yoichiro Takayanagi, Shimako Nishiyama, Yuko Higuchi, Atsushi Furuichi, Mikio Kido, Kyo Noguchi & Michio Suzuki. (2019) Reduced pineal gland volume across the stages of schizophrenia. Schizophrenia Research 206, pages 163-170.
Crossref
Crossref
Magalie Lussier-Valade, Alex Desautels & Roger Godbout. (2020) Troubles psychotiques et troubles du sommeil : revue de la littérature. Santé mentale au Québec 44:2, pages 163-194.
Crossref
Crossref
Sophie Faulkner & Penny Bee. (2017) Experiences, perspectives and priorities of people with schizophrenia spectrum disorders regarding sleep disturbance and its treatment: a qualitative study. BMC Psychiatry 17:1.
Crossref
Crossref
Adam Elias Brøndsted, Birgitte Haargaard, Birgit Sander, Henrik Lund-Andersen, Poul Jennum & Line Kessel. (2017) The effect of blue-blocking and neutral intraocular lenses on circadian photoentrainment and sleep one year after cataract surgery. Acta Ophthalmologica 95:4, pages 344-351.
Crossref
Crossref
Annaëlle Charrier, Bertrand Olliac, Pierre Roubertoux & Sylvie Tordjman. (2017) Clock Genes and Altered Sleep–Wake Rhythms: Their Role in the Development of Psychiatric Disorders. International Journal of Molecular Sciences 18:5, pages 938.
Crossref
Crossref
Lone Baandrup, Ole Bernt Fasmer, Birte Yding Glenthøj & Poul Jørgen Jennum. (2016) Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial. BMC Psychiatry 16:1.
Crossref
Crossref
Anne-Sofie Johansson, Björn Owe-Larsson, Jerker Hetta & Gabriella B. Lundkvist. (2016) Altered circadian clock gene expression in patients with schizophrenia. Schizophrenia Research 174:1-3, pages 17-23.
Crossref
Crossref
Sarah Reeve, Bryony Sheaves & Daniel Freeman. (2015) The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review. Clinical Psychology Review 42, pages 96-115.
Crossref
Crossref
George Anderson & Michael Maes. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
307
320
.
Lauren D. Asarnow, Adriane M. Soehner & Allison G. Harvey. (2013) Circadian rhythms and psychiatric illness. Current Opinion in Psychiatry 26:6, pages 566-571.
Crossref
Crossref
Jaime M. Monti, Ahmed S. BaHammam, Seithikurippu R. Pandi-Perumal, Vivien Bromundt, D. Warren Spence, Daniel P. Cardinali & Gregory M. Brown. (2013) Sleep and circadian rhythm dysregulation in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 43, pages 209-216.
Crossref
Crossref
Masoud Tahmasian, Habibolah Khazaie, Sanobar Golshani & Kristin T. Avis. (2013) Clinical Application of Actigraphy in Psychotic Disorders: A Systematic Review. Current Psychiatry Reports 15:6.
Crossref
Crossref
Armando Morera-Fumero & Pedro Abreu-Gonzalez. (2013) Role of Melatonin in Schizophrenia. International Journal of Molecular Sciences 14:5, pages 9037-9050.
Crossref
Crossref
George Anderson & Michael Maes. (2012) Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metabolic Brain Disease 27:2, pages 113-119.
Crossref
Crossref